Peptides are the frontier of regenerative medicine — short chains of amino acids (typically 2-50) that signal specific biological processes. Unlike broad-spectrum drugs, peptides tend to work on targeted pathways: healing, growth, immune modulation, or neuroprotection. The research is promising. The regulatory landscape is messy. Here's what you need to know.
What Peptides Are
Peptides are small proteins. Your body produces thousands of them naturally — insulin is a peptide, oxytocin is a peptide, growth hormone-releasing hormone is a peptide. Therapeutic peptides are synthetic versions of natural signaling molecules designed to amplify specific physiological processes.
Why they're interesting:
- High specificity (targeted action vs. broad systemic effects)
- Generally well-tolerated (your body recognizes the molecular structure)
- Emerging evidence for applications where conventional medicine has limited options (tendon repair, gut healing, neuroregeneration)
Why they're complicated:
- Most are injectable (peptides are destroyed in the GI tract — with some exceptions)
- Regulatory gray area (many aren't FDA-approved for the marketed uses)
- Quality control is a serious concern (research chemical supply chains vary widely)
- Clinical data is largely preclinical (animal/cell studies), with limited human RCTs
The Key Peptides
BPC-157 (Body Protection Compound)
What it does: Accelerates healing of tendons, ligaments, muscles, gut lining, and potentially nerve tissue. Derived from a protein found in human gastric juice.
The evidence:
- Extensive animal data showing accelerated healing of: Achilles tendons, muscle tears, damaged gut lining, nerve damage, and bone fractures
- Mechanism: upregulates growth factor expression (VEGF, EGF), promotes angiogenesis, modulates nitric oxide pathways
- Oral BPC-157 has data for gut-specific applications (it's one of the few peptides that survives gastric acid)
Human data: Limited. Case reports and clinical observations, but no large RCTs published as of 2026. The animal data is extensive and consistent, which is why it's widely used despite the evidence gap.
Use case: Injury recovery, gut healing (leaky gut, IBS, post-NSAID damage), tendon/ligament repair
TB-500 (Thymosin Beta-4)
What it does: Promotes cell migration, wound healing, and reduces inflammation. Thymosin beta-4 is naturally produced and involved in tissue repair throughout the body.
The evidence:
- Strong preclinical data for cardiac repair post-infarction
- Promotes hair follicle stem cell migration (hair regrowth potential)
- Reduces fibrosis and scar tissue formation
- Anti-inflammatory via downregulation of inflammatory cytokines
Use case: Soft tissue injuries, chronic inflammatory conditions, post-surgical recovery. Often stacked with BPC-157 for synergistic healing effects.
GHK-Cu (Copper Peptide)
What it does: A naturally occurring tripeptide-copper complex that declines with age (plasma levels drop ~60% between age 20 and 60). Involved in wound healing, collagen synthesis, antioxidant enzyme upregulation, and anti-inflammatory signaling.
The evidence:
- Topical: Stimulates collagen I and III synthesis, improves skin elasticity and thickness, reduces fine lines. The dermatological data is robust.
- Systemic: Animal data suggests anti-fibrotic, anti-inflammatory, and neuroprotective properties
- Gene expression studies show GHK-Cu modulates expression of ~32% of human genes, resetting many to a more youthful expression pattern
Use case: Skin aging (topical), systemic anti-aging (injectable), wound healing, hair health
CJC-1295 / Ipamorelin (Growth Hormone Secretagogues)
What they do: Stimulate your pituitary to release more growth hormone, mimicking the natural pulsatile GH release pattern.
- CJC-1295: GHRH analog that increases GH and IGF-1 levels
- Ipamorelin: Ghrelin mimetic that selectively stimulates GH release without significantly raising cortisol or prolactin
Use case: Age-related GH decline, body recomposition, recovery optimization. Often stacked together for synergistic pulsatile GH release.
Caution: Elevated IGF-1 over prolonged periods has theoretical cancer-promotion concerns (IGF-1 is a growth signal — it doesn't discriminate between healthy and cancerous cells). Monitor IGF-1 levels and discuss cancer history with your physician.
Important Caveats
Quality and Sourcing
The peptide market is largely unregulated. "Research chemical" peptides vary enormously in purity, potency, and contamination. Third-party testing (HPLC purity analysis, endotoxin testing) is essential. Compounding pharmacies that specialize in peptides are generally more reliable than random online vendors.Legal Status
In the US, the FDA has cracked down on compounding pharmacies selling certain peptides. BPC-157 and others have been removed from compounding pharmacy formularies in some jurisdictions. The landscape is shifting — check current regulations in your area.The Evidence Gap
Most peptide research is preclinical. Animal models are informative but not conclusive. The gap between "this healed a rat tendon in 14 days" and "this will heal your tendon" is significant. Proceed with informed caution, not blind enthusiasm.Administration
Most peptides require subcutaneous injection. This involves:- Reconstituting lyophilized powder with bacteriostatic water
- Proper storage (refrigeration)
- Sterile injection technique
- Understanding dosing in micrograms
The Responsible Approach
- Educate yourself thoroughly before considering any peptide
- Work with a physician experienced in peptide therapy (anti-aging or sports medicine doctors)
- Source from reputable compounding pharmacies with third-party testing
- Monitor biomarkers — regular bloodwork including IGF-1, inflammatory markers, and metabolic panel
- Start conservative — lowest effective dose, single peptide at a time
- Don't rely on peptides as primary treatment — they're adjuncts to proper training, nutrition, sleep, and conventional medicine
Who This Is For
Peptides occupy a space between conventional medicine and performance optimization. They're most appropriate for:
- People with injuries that haven't responded to standard treatment
- Age-related decline in recovery and healing capacity
- Specific gut issues where standard approaches have been insufficient
- Informed adults who understand the risk-benefit calculus and work with qualified practitioners
- Anyone looking for a shortcut without doing the basics (sleep, nutrition, training)
- People unwilling to monitor with bloodwork
- Anyone who can't access proper medical guidance